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1064Objective: Few studies have examined the association between procedural volume and clinical outcomes in heart
transplantation. This retrospective study was performed on a contemporary cohort of heart transplant recipients to
better elucidate the effect of transplant center volume on 1-year mortality.
Methods: Data from the Scientific Registry of Transplant Recipients were used to analyze the relationship be-
tween transplant center volume and short-term survival. Center volume designation (very low, low, medium,
and high) was assigned on the basis of quartiles with approximately equal numbers of patients per group. Survival
differences were explored using Cox proportional hazards modeling to adjust for differences in variables between
volume groups and to determine variables associated with 1-year mortality.
Results:Between January 1, 1999, andMay 31, 2005, 13,230 heart transplantations were performed at 147 trans-
plant centers in the United States. Although most recipient and donor characteristics were similar across quartiles,
larger volume centers were more likely to perform transplantations in older candidates and accept organs from
older donors with longer cold ischemia times. A statistically significant relationship between transplant center
volume and 1-year mortality was observed. Compared with the reference group (very low volume), the hazard
ratios for the low, medium, and high-volume quartiles were 0.71, 0.64, and 0.56, respectively (P< .001 for
each group compared with the reference).
Conclusion: There was a significant association between transplant center volume and 1-year survival. Patients
who undergo cardiac transplantation at very low-volume centers are at higher risk for early mortality than those
who undergo transplantation in higher-volume centers. (J Thorac Cardiovasc Surg 2010;139:1064-9)There is substantial evidence to suggest a strong association
between center volume and outcomes, including survival, for
a variety of complex surgical procedures.1,2 Centers with
higher patient volume demonstrate improved early and
long-term survival for cardiac surgical procedures, aortic an-
eurysm surgery, cancer surgery, and liver and kidney trans-
plantation.2-5 Potential reasons for this effect include
provider experience, better surgical technique and postoper-
ative care, broader access to experienced ancillary care ser-
vices, and selective referral to hospitals with better outcomes.
In the United States, more than 660,000 patients are diag-
nosed with heart failure every year.6 Despite impressive
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The Journal of Thoracic and Cardiovascular Surtation is frequently the best option for highly selected patients
with end-stage heart failure. Patients who undergo transplan-
tation require a complex, well-organized, and technically
sophisticated level of care. This level of care must extend be-
yond the physical domains of the transplant center to the site
of the potential organ donor, thus adding to the complexity of
the organ transplant process. Despite this level of
sophistication, international experience in cardiac transplan-
tation demonstrates a 1-year survival of approximately 84%
and a 10-year survival of approximately 50%.7 Mortality
results from a complex interplay of donor and recipient char-
acteristics, limitations of organ preservation, immunologic
barriers, and surgical complexity. In most transplant centers,
perioperative care is largely dictated by institutional proto-
cols that are tailored to the individual donor and recipient.
In addition, adequate and experienced consultative and ancil-
lary services are necessary for successful outcomes in this
highly vulnerable group of patients. This level of complexity
in medical care services likely varies from center to center
and may be more available in centers with larger patient
volumes.8 Previous studies of cardiac transplant center vol-
ume outcomes have involved small patient numbers or
limited the risk adjustment to a fewvariables.9,10 The primary
objective of this study was to determine the effect of trans-
plant center volume on 1-yearmortality differences and iden-
tify clinical variables between heart transplant centers with
different patient volumes and mortalities.gery c April 2010
TABLE 1. Heart transplant center characteristics by volume quartile
Abbreviations and Acronyms
ICU ¼ intensive care unit
MPSC ¼ Membership and Professional
Standards Committee
OPTN ¼ Organ Procurement and Transplantation
Network
SRTR ¼ Scientific Registry of Transplant
Recipients
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Data Source
National data on all patients who undergo solid organ transplantation are
collected by the Organ Procurement and Transplantation Network (OPTN)
and analyzed by the Scientific Registry of Transplant Recipients (SRTR)
under a contract administered by the US Department of Health and Human
Services andHealth Resources and Services Administration. Project officers
for the SRTR and Health Resources and Services Administration approved
this study and determined that it satisfies criteria for institutional review
board exemption.
Study Population
The analysis was performed for all adult patients who underwent heart
transplantation in the United States from January 1, 1999, to May 31,
2005. Donor and recipient data available for analysis included demographic
and clinical information, and outcome (survival) information. Center-spe-
cific information included number of transplants performed during the
time period specified. Transplant center case volume was determined by
the number of transplantations performed during the defined study period
divided by the number of calendar years for which the center submitted
data to the OPTN. Annual heart transplant volumes were categorized into
quartiles (very low, low, medium, and high volumes) with cut points chosen
to achieve approximate equal numbers of patients per quartile (1–11, 12–21,
22–33, and>34 heart transplants per year). The primary outcome was
1-year mortality.
Statistical Analysis
Differences in variables among center volume groups were explored us-
ing the chi-square analysis for categoric variables or the Student t test for
continuous variables. The very low-volume center was used as the baseline
comparison group. Donor variables analyzed include age, gender, and cold
ischemia time. Recipient variables analyzed include age, gender, race, body
mass index, diagnoses (including primary reason for transplantation, pres-
ence of hypertension, diabetes, need for renal replacement therapy, or me-
chanical ventilation), creatinine, bilirubin, cardiac output, and presence or
absence of a left ventricular assist device. Relative risk was evaluated using
Cox proportional hazards modeling to adjust for volume quartiles and other
variables associated with early (1-year) mortality. An alpha of 0.05 was con-
sidered to represent statistical significance. All analyses were conducted us-
ing SAS version 9.1 (SAS Institute Inc, Cary, NC).
Volume quartile
Very low Low Medium High
No. of transplants 3089 3546 3370 3225
No. of centers 84 35 19 9
Median annual
volume per center
5 16 28 48
Median years
experience per center
5.9 6.3 6.4 6.4
T
XRESULTS
Heart Transplant Center, Donor, and Recipient
Characteristics
Between January 1, 1999, and May 31, 2005, 13,230
first-time heart transplants were performed at 147 transplant
centers in the United States. During this time period, trans-The Journal of Thoracic and Carplant center volume varied widely. Very low-volume centers
performed between zero and 12 transplantations per year
(median¼ 5), low-volume centers performed between 13
and 21 transplantations per year (median¼ 16), medium-
volume centers performed between 22 and 33 transplanta-
tions per year (median¼ 28), and high-volume centers per-
formed between 34 and 88 transplantations per year
(median¼ 48) (Table 1).
Donor characteristics varied modestly across the volume
quartiles. There was a trend toward larger centers accepting
a higher proportion of donor hearts fromwomen, with the dif-
ference between very low (reference group) and high-volume
quartile centers reaching statistical significance (P<.001) (Ta-
ble 2). High-volume centers were also more likely to accept
a lower proportion of hearts from donors aged 18 to 39 years
and a higher proportion of hearts from donors aged more
than 50 years than very low-volume centers. In addition, there
was a linear trend of longer cold ischemia times accepted by
centers of higher transplant volume,with the difference among
very low and low,medium, and high-volume centers all reach-
ing statistical significance (P< .001, all groups).
Recipient characteristics also varied substantially among
volume quartiles. There were fewer recipients of age 35 to
64 years in the high-volume quartile and more recipients
of age 65 years and more in the medium and high-volume
quartiles than in the very low-volume quartile (P< .001
for each group) (Table 3). Low and medium-volume quartile
centers seemed more likely to perform transplantations in
white patients than the very low-volume quartile centers.
The percentage of recipients of African-American descent
seemed to be relatively equal across volume quartiles.
High-volume quartile centers were more likely to perform
transplantations in patients with a primary diagnosis of
‘‘other’’ (eg, valvular, infiltrative, or congenital disease)
(P¼ .03), although the majority of patients in all volume
quartiles carried the primary diagnosis of cardiomyopathy
of ischemic or nonischemic origin, as expected. Medium
and high-volume quartile centers performed transplantations
in a smaller proportion of patients with a body mass index of
35 kg/m2 or greater. Although there were statistical differ-
ences in biochemical data and hemodynamics, the magni-
tude of the difference was small. The percentage ofdiovascular Surgery c Volume 139, Number 4 1065
TABLE 2. Heart transplant donor characteristics by volume quartile
Volume quartile
mean or% (P value*)
Very low Low Medium High
Donor characteristics
Male (%) 72% 70% (.08) 70% (.09) 67% (<.001)
Age (y)
<18 13% 13% (.60) 12% (.67) 11% (.08)
18–39 59% 57% (.23) 58% (.86) 55% (.004)
40–49 20% 20% (.77) 20% (.68) 21% (.31)
50 9% 10% (.08) 9% (.83) 13% (<.001)
Cold ischemia
time (min)
173.1 180.7 (<.001) 190.1 (<.001) 203.3 (<.001)
*Reference group is the very low transplant volume category.
TABLE 3. Heart transplant recipient characteristics by volume
quartile
Volume quartile
mean or% (P value*)
Very
low Low Medium High
Recipient characteristics
Male (%) 76% 75% (.54) 77% (.20) 77% (.29)
Recipient age (y)
18–34 11% 11% (.63) 8% (<.001) 10% (.14)
35–64 81% 81% (.80) 79% (.05) 75% (<.001)
65 8% 8% (.35) 13% (<.001) 15% (<.001)
Race
White 74% 80% (<.001) 77% (.001) 76% (.09)
African-American 15% 14% (.37) 15% (.69) 14% (.43)
Hispanic 8% 5% (<.001) 6% (<.001) 7% (.03)
Asian 2% 1% (.003) 1% (.001) 3% (.37)
Cardiothoracic Transplantation Shuhaiber et al
T
Xpatients supported with a ventricular assist device was ap-
proximately equal among the volume quartiles.
Diagnosis
Nonischemic 46% 46% (.87) 47% (.38) 45% (.40)
Ischemic 49% 48% (.56) 48% (.49) 48% (.51)
Other 5% 6% (.36) 5% (.66) 7% (.003)
Body mass index (kg/m2)
<18 3% 3% (.19) 3% (.20) 4% (.43)
18–24 33% 33% (.85) 34% (.37) 36% (.01)
25–29 37% 37% (.99) 36% (.31) 33% (<.001)
30–34 16% 18% (.17) 17% (.24) 14% (.04)
35 4% 4% (.79) 3% (.007) 2% (<.001)
Creatinine (mg/dL) 1.35 1.36 (.25) 1.40 (.06) 1.39 (<.001)
Bilirubin (mg/dL) 1.34 1.39 (.33) 1.22 (.20) 1.32 (.15)
Hypertension, drug
treated
38% 39% (.32) 41% (.03) 31% (<.001)
Diabetes, any 17% 19% (.14) 19% (.05) 17% (.85)
Cardiac output,
pretransplant (L/min)
4.52 4.61 (<.001) 4.58 (.007) 4.51 (<.001)
Dialysis before
transplant
3% 3% (.61) 4% (<.001) 2% (.11)
Mechanical ventilation 3% 4% (.02) 2% (.25) 3% (.67)
Ventricular assist device 15% 17% (.11) 17% (.09) 14% (.20)
*Reference group is the very low transplant volume category.Survival Analysis
Multivariate modeling was used for determination of risk
factors for 1-year posttransplant mortality. Adjusted survival
analysis among the volume quartile groups demonstrated
a significantly decreased 1-year risk for mortality in the
low, medium, and high-volume quartile centers when com-
pared with centers in the very low-volume quartile (Fig-
ure 1). Compared with the reference (very low-volume)
group, the hazard ratios for the low, medium, and high-vol-
ume quartiles were 0.71, 0.64, and 0.56, respectively (P<
.001 for each group compared with the reference group).
Additional analysis demonstrated other risk factors for
survival. Donor variables associated with inferior 1-year sur-
vival included age greater than 40 years, female gender, and
longer ischemia time (Table 4). Recipient variables associ-
ated with inferior 1-year survival included age 65 years or
more and female gender. No difference was observed be-
tween racial groups. The primary diagnosis of nonischemic
cardiomyopathy seemed to incur less risk compared with the
diagnosis of ischemic cardiomyopathy, whereas the
diagnosis of ‘‘other’’ cardiomyopathy (eg, valvular, infiltra-
tive, and congenital diseases) incurred additional risk. The
presence of hypertension, diabetes (preoperative), dialysis,
or mechanical ventilation was associated with increased
risk. Biochemical markers associated with increased risk in-
cluded elevated levels of serum creatinine and bilirubin.
Higher recipient (preoperative) cardiac output was associ-
ated with a lower risk for mortality. The presence of a left
ventricular assist system was associated with a higher risk
of posttransplant mortality.DISCUSSION
The surgical and medical management of the heart trans-
plant recipient is highly complex. Mortality within the first
90 days and 1 year after heart transplantation has been re-
ported to be 8.3% and 12.7%, respectively, indicating that1066 The Journal of Thoracic and Cardiovascular Surthe risk for poor outcomes is substantial.11 One of the hall-
mark mechanisms of quality assessment in outcomes for
high-complexity procedures is analysis of case mix and
case volume.5 Comparison of hospital volume effect on out-
comes may reflect the ability of certain medical teams to
attain superior results. This study demonstrates that donor
and recipient risk-adjusted 1-year survival for heart trans-
plantation is superior in centers that perform a higher volume
of heart transplants. These results are similar to those dem-
onstrated for transplantation of other solid organs.4,12 As
an example, the risk-adjusted likelihood of 1-year allograft
survival in kidney transplantation has been demonstrated
to be approximately 21% superior in high-volume centers
compared with very low, low, and medium-volume centers.
Similarly, the risk-adjusted likelihood of 1-year patientgery c April 2010
FIGURE 1. Risk-adjusted patient survival. Each curve describes survival
of a hypothetic cohort of patients with average values within each volume
quartile.
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be approximately 30% superior in high-volume centers
compared with low-volume centers.4
Superior outcomes in heart transplantation have been
demonstrated, albeit in a smaller cohort of patients and an
earlier era. Hosenpud and colleagues10 demonstrated an in-
creased risk of mortality at 1 month and 12 months (40%
and 33%, respectively) in centers performing fewer than 9
cardiac transplantations per year between the years of
1987 and 1991. In addition, a recent European study that
evaluated 1401 heart transplants performed over a 2-year pe-
riod also demonstrated a small, yet significant, association
between center volume and posttransplant mortality.9 The
fact that there remains a difference in outcome based on cen-
ter volume in the more contemporary cohort of heart trans-
plant recipients evaluated in our study demonstrates that
there are opportunities to improve.
Surgeon and surgical team experience are important for
excellent outcomes in all fields that require technical mastery.
Less obvious, but perhaps equally important, are other aspects
of the care of patients posttransplantation. For example, treat-
ment in the intensive care unit (ICU) is of paramount impor-
tance, and thus it should be anticipated that the experience of
the ICU team influences outcome. It is reasonable to assume
that larger-volume centers have ICU care teams that are more
versatile and adept in the care of complex cases. This has been
demonstrated in neonatal ICUs in California, where mortality
among very low birth weight infants seemed to be lowest in
high-volume ICUs.13 No less important is nursing care in
themanagement of cardiac transplant recipients.Nursing staff
who have been exposed to a larger number of transplant recip-
ients can be expected to bemore familiarwith their needs, rec-
ognition of complications, and general postoperative care.14
The strategy for optimal management of heart transplant
recipients is seldom straightforward. There are many aspects
of their illness and posttransplant care plan that makes them
vulnerable to medical complications, such as infections, re-
nal insufficiency, and immunologic complications. There-The Journal of Thoracic and Carfore, it is also reasonable to assume that consultative
services with more experience in issues of transplantation
(not necessarily heart) are also important for successful out-
comes within a transplant program. Long-term care of heart
transplant recipients is also dependent on cardiologists who
specialize in heart failure and transplantation, as well as on
social workers and financial consultants who have particular
experience in transplantation.
Our results do not demonstrate that all very low-volume
centers underperform; in fact, many smaller programs have
exceptional outcomes, and we do not imply that transplanta-
tion should not occur in small-volume centers. Elimination of
all low-volume centers would likely make transplantation an
unobtainable option for certain patients. As an example,
a low-volume center may have a lower than expected sur-
vival, but elimination of such a programmight mean that pa-
tients would have to travel an unacceptable distance to be
considered for transplantation. Conversely, it is reasonable
to reconsider the appropriateness of allowing transplantation
to occur at a low-volume center that consistently underper-
forms if it is within the proximity of a larger and more expe-
rienced center with better outcomes. In short, these results do
not take into account the need for equal access to care based
on geographic, financial, and social realities that exist for our
patients and their families.
Further research as to the reasons for the discrepancy in
results between centers that perform above and below expec-
tations is a worthwhile endeavor. In a recent volume-
outcome publication based on United Network for Organ
Sharing data, Weiss et al15 also found center volume to be
an independent predictor of short-term mortality. The
authors advocated re-evaluation of the current volume cutoff
of 10 heart transplant cases recommended by Centers for
Medicare and Medicaid Services. They reached this conclu-
sion despite lack of adjustment for important variables, such
as dialysis, ventricular assist device, age group stratification,
and type of cardiomyopathy. Nonetheless, their analysis
based on a contemporary host of transplant centers recon-
firmed that a volume–outcome relationship exists but did
not provide any mechanisms.
This study reconfirms these findings once again with more
variable risk adjustment providing a robust conclusion that
is front loaded. Most of the differences occur early on related
to surgery, rejection, and infection.
There is substantial interest by payers, media, and govern-
ment institutions (eg, the Department of Health and Human
Services) in outcomes and quality control and improvement
for complex and expensive therapies; transparency of pro-
grammatic clinical outcomes is becoming not only desirable
but also mandatory. In addition, patients and families are be-
coming savvy at deciphering such information as it becomes
more available in the current information era.
A system for maintaining quality outcomes in solid organ
transplantation is currently in effect.16 The Membership anddiovascular Surgery c Volume 139, Number 4 1067
TABLE 4. Factors associated with recipient mortality at 1 year
posttransplant
Parameter Hazard ratio 95% CI P value
Donor characteristics
Age (y)
0–17 1.004 (0.85–1.18) .96
18–39 1.000 REF REF
40–49 1.24 (1.09–1.40) .001
50 1.50 (1.29–1.75) <.001






18–34 1.06 (0.89–1.27) .50
35–64 1.00 REF REF
65 1.35 (1.16–1.57) <.001
Male (vs female) 0.87 (0.77–0.99) .03
Race
White 1.00 REF REF
African-American 1.14 (0.99–1.32) .07
Hispanic 1.05 (0.85–1.28) .67
Asian 1.07 (0.75–1.53) .72
Other 1.27 (0.73–2.20) .40
Diagnosis
Ischemic 1.00 REF REF
Nonischemic 0.87 (0.77–0.97) .02
Other 1.32 (1.09–1.61) .006
Body mass index (kg/m2)
<18 1.33 (1.01–1.74) .002
18–24 1.00 REF REF
25–29 1.17 (1.03–1.32) .02
30–34 1.19 (1.02–1.39) .03
35 1.11 (0.84–1.48) .47
Creatinine (mg/dL) 1.12 (1.08–1.17) <.001
Bilirubin (mg/dL) 1.04 (1.03–1.04) <.001
Hypertension, drug treated 1.31 (1.02–1.26) .02
Diabetes (any vs none) 1.15 (1.01–1.31) .03
Cardiac output (L/min) 0.93 (0.90–0.97) <.001
Dialysis before transplant 1.74 (1.41–2.14) <.001
Mechanical ventilation 2.50 (2.07–3.01) <.001
Ventricular assist device 1.46 (1.29–1.66) <.001
Center volume
Very low 1.00 REF REF
Low 0.71 (0.62–0.82) <.001
Medium 0.64 (0.56–0.74) <.001
High 0.56 (0.48–0.65) <.001
CI, Confidence interval; REF, reference group.
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evaluates programs with low 1-year transplant grafts and
survivals. Centers defined as needing review are identified,
in part, by organ-specific Cox proportional hazard models
that have been developed by the SRTR at the request of
the MPSC. The variables used in these models are listed
on the SRTR website.17 However, MPSC review of institu-
tions is time and resource intensive. Accuracy and cost-1068 The Journal of Thoracic and Cardiovascular Sureffectiveness of the current methodology for identifying pro-
grams that underperform are currently under review by the
MPSC.18
Limitations
Our study has limitations. Most important, and as stated
above, these results define association, not specific causality.
Although the dataset used is robust and comprehensive,
there are limitations to the quantity and quality of data col-
lected by the OPTN, and there may have been important var-
iables for which no adjustment was made. For example,
specifics of the actual surgical procedure, such as individual
surgeon experience,19 location within a teaching hospital,
and contribution from trainees such as surgical residents or
fellows, are not accounted for in this study.20 In addition,
we did not characterize annual variation across centers given
that it was not a predictor in prior studies9,10,15 and given the
constraints of the data. Although the actual surgical tech-
nique used is somewhat standard, there are variations that
may affect overall outcomes, such as use of a bicaval anas-
tomosis technique, which better preserves donor cardiac
anatomy, specifically the right atrium and tricuspid valve.21
Issues such as these are difficult to explore in full with a ret-
rospective analysis of this database, although ischemia time,
an important variable, and a modest surrogate for transplant
complexity, was included in our analysis.
In addition to the technical aspects of cardiac transplanta-
tion mentioned above, there are other variables that were not
fully explored. Nurse to patient ratio, open versus closed
ICU,22 and other social and otherwise patient-specific issues
that may differ significantly between low and high-volume
transplant centers were not included in this analysis.
Selection bias certainly exists between low and high-vol-
ume centers, either on the part of referring physicians or the
transplant center physicians themselves. Although this can,
and probably does, influence our results to a degree, we be-
lieve that with inclusion of the above described donor and
recipient clinical variables, the likelihood that this would
nullify our findings has been minimized.
CONCLUSIONS
Higher-volume heart transplant centers use higher-risk or-
gans in that they use older donors and donors with longer is-
chemia times. There is a less clear pattern of risk seen with
recipient variables, although higher-volume transplant cen-
ters perform transplantations in older patients. By adjusting
for donor and recipient variables, the cohort of patients re-
ceiving transplants in very low-volume centers demon-
strated a 29% to 44% increased relative risk of mortality
at 1 year posttransplant. Further interventions aimed at im-
proving quality in low-volume centers (where approxi-
mately one quarter of all heart transplants are performed in
the United States) are in order and may offer possibilities
for quality improvement in the field of heart transplantation.gery c April 2010
Shuhaiber et al Cardiothoracic TransplantationPossible explanations for better outcomes in higher-volume
centers are worth further inquiry to export their methods to
lower-volume centers, specifically to the very low-volume
centers.
We thank the SRTR members for support.
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